A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine
Clinical trial NCT06088745 · RECRUITING
Trial details
- NCT number
- NCT06088745
- Sponsor
- Beijing Luzhu Biotechnology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-28
- Primary completion
- 2024-12-31
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.